Forget Digitial Differentiation: Focus on Cross-Channel 'Fusion'
Forget digital differentiation and innovation. You need to be focusing on cross-channel ‘fusion’, says Fonny Schenck. With this imperative in mind, Peter Houston, got in touch with... Read more
Article: Analysis paralysis?
Highly versed in customer relationship management (CRM) and eCRM, Fonny Schenck looks at the current need for fusion between online and offline data management. His vision of the ‘New Normal’ in... Read more
Across Health is searching for a senior 'fusion' consultant in Spain
Job description You will work with several key life-sciences customers in Spain on short or longer-term projects, ranging from insight generation throught cross-channel strategy formulation,... Read more
Across Health interviewed for Forrester report on interactive marketing in healthcare
Across Health’s Fonny Schenck was recently interviewed for an August 2012 Forrester report “Innovate Interactive Healthcare Marketing Without Rocking The Boat”.  The report confirms that life... Read more
Across Health acquires a majority stake in Signature Pharma
Across Health announced today the acquisition of a majority stake in Signature Pharma, a leading digital consultancy for life sciences in Spain, which is managing innovative digital marketing and... Read more

Most Recent News

Most Recent News

Digital health perspectives
Rebecca Aris (www.pharmaphorum.com) interviews Fonny Schenck. Digital will have to be integrated with other channels, in most cases. And that’s what we call fusion....
Posted 03 May 2013
Nutraceuticals: Big Pharma or Big Food’s next Big Growth area?
Think about the last time you made a visit to a GP as a patient. If it was a sick visit, you presented with a series of symptoms. Your doctor asked about them, and...
Posted 22 April 2013
Forget Digitial Differentiation: Focus on Cross-Channel 'Fusion'
Forget digital differentiation and innovation. You need to be focusing on cross-channel ‘fusion’, says Fonny Schenck. With this imperative in mind, Peter...
Posted 18 April 2013

Trending Pharma News